# A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients

> **NCT01389583** · PHASE2 · UNKNOWN · sponsor: **National Health Research Institutes, Taiwan** · enrollment: 25 (estimated)

## Conditions studied

- Gastrointestinal Stromal Tumor

## Interventions

- **DRUG:** AUY922

## Key facts

- **NCT ID:** NCT01389583
- **Lead sponsor:** National Health Research Institutes, Taiwan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-10
- **Primary completion:** 2015-05
- **Final completion:** 2019-10
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2015-02-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01389583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01389583, "A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01389583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*